Related references
Note: Only part of the references are listed.Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial
Brigitte Granel et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
Philippe Bourin et al.
CYTOTHERAPY (2013)
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
O. Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Recombinant Human Relaxin in the Treatment of Systemic Sclerosis With Diffuse Cutaneous Involvement A Randomized, Double-Blind, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2009)
Assessing disability and quality of life in systemic sclerosis:: Construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), systemic sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey
Francois Rannou et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
PA Merkel et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
